Last Updated: November 16, 2026

Details for Patent: 12,097,284

« Back to Dashboard


Which drugs does patent 12,097,284 protect, and when does it expire?

Patent 12,097,284 protects MYHIBBIN and is included in one NDA.

This patent has four patent family members in three countries.

Summary for Patent: 12,097,284
Title:Mycophenolate oral suspension
Abstract:Disclosed herein are pharmaceutical compositions in the form of a suspension for oral delivery. Some embodiments provide a pharmaceutical composition in the form of a suspension for oral delivery comprising an active pharmaceutical ingredient; water; a suspending agent; a buffering agent; and one or more of a wetting agent and a binder/filler. In some embodiments, the active pharmaceutical ingredient is selected from quetiapine, sildenafil, tadalafil, cinacalcet, ticagrelor, mycophenolate, aprepitant, zonisamide, and primidone.
Inventor(s):Sandip Mehta, Manish Kumar Umrethia, Jayanta Mandal
Assignee: Liqmeds Worldwide Ltd
Application Number:US18/442,765
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 12,097,284

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Azurity MYHIBBIN mycophenolate mofetil SUSPENSION;ORAL 216482-001 May 1, 2024 RX Yes Yes 12,097,284 ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 12,097,284

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3836898 ⤷  Start Trial
United Kingdom 202103764 ⤷  Start Trial
United Kingdom 2591396 ⤷  Start Trial
World Intellectual Property Organization (WIPO) 2020039263 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.